SCHEMBL180252

SCHEMBL180252

COc1cc(OC)c(P(c2c(OC)cc(OC)cc2OC)c2c(OC)cc(OC)cc2OC)c(OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CYP1A2 P05177 8/20 0.43
CYP3A4 P08684 6/20 0.43
CYP1A1 P04798 7/20 0.41
CYP1B1 Q16678 7/20 0.41
MAPK1 P28482 2/20 0.41
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ERN1 O75460 1/20 0.41
CYP2C19 P33261 3/20 0.38
CYP2E1 P05181 2/20 0.38
CYP2C8 P10632 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2A6 P11509 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31325535 0.97 ALDH1A1 (0.48) ALDH1A1CA12CA1CA2CA7
Bromide SCHEMBL20424457 0.97 ALDH1A1 (0.48) ALDH1A1CA12CA1CA2CA7
SCHEMBL15094975 0.93 ALDH1A1 (0.43) ALDH1A1CA12CA1CA2CA7
Acetic Acid SCHEMBL4282570 0.87 CYP3A4 (0.50) ALDH1A1CA12CA1CA2CA7
SCHEMBL31747503 0.86 CA12 (0.37) ALDH1A1CA12CA1CA2CA7
Propylamine SCHEMBL12465622 0.85 CYP1A2 (0.47) ALDH1A1CA12CA1CA2CA7
SCHEMBL31747558 0.84 CA12 (0.35) ALDH1A1CA12CA1CA2CA7
SCHEMBL25053617 0.82 CA12 (0.52) ALDH1A1CA12CA1CA2CA7
SCHEMBL10702455 0.81 CA4 (0.43) ALDH1A1CA12CA1CA2CA7
SCHEMBL6754210 0.80 ALDH1A1 (0.46) ALDH1A1CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 757 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3964540-B1 CHEMICALLY MODIFIED ANION EXCHANGE MEMBRANE AND METHOD OF PREPARING THE SAME DANKOOK UNIV CHEONAN CAMPUS INDUSTRY ACADEMIC CORPORATION FOUNDATION (KR) 2026-04-01 EP claimed
US-12521708-B2 Doped anion exchange membranes (AEMs) for highly selective separators in electrochemical devices WASHINGTON UNIVERSITY (US) 2026-01-13 US claimed
EP-4673452-A1 PHOTOBASES TECHNISCHE UNIVERSITÄT WIEN (AT) 2026-01-07 EP claimed
EP-4667939-A1 MULTIPLEX CANCER CELL PROFILING USING MS-TAGGED PROBES CONTAINING AN IMINOSYDNONE CLEAVABLE LINKER Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2025-12-24 EP claimed
EP-4222500-B1 METHODS OF DETECTING ISOASPARTIC ACID AMGEN INC (US) 2025-11-12 EP claimed
EP-4590766-A1 PHOTORESIN FORMULATIONS AND USE THEREOF FOR VOLUMETRIC ADDITIVE MANUFACTURING National Research Council of Canada (CA) 2025-07-30 EP claimed
EP-2427468-B2 PREPARATION OF A METAL COMPLEX JOHNSON MATTHEY PLC (GB) 2025-06-04 EP claimed
CN-116410088-B Synthesis method of alpha-aryl propionate compound 南京工业大学 2025-05-02 CN claimed
CN-116217901-B Preparation method of high isotactic poly (lactide) 吉林大学 2025-04-18 CN claimed
CN-116217902-B Preparation method of high-stereoregularity polylactide 吉林大学 2025-04-18 CN claimed
US-20050038305-A1 Process for producing 1-octene from butadiene SHELL USA, INC. 2005-02-17 US claimed
US-20050037940-A1 Process for producing detergent molecules comprising an ether linkage from butadiene SHELL OIL COMPANY 2005-02-17 US claimed
US-20040260039-A1 Process for producing organic compound epoxy resin composition, cured article obtained from the epoxy resin, and semiconductor device obtained with epoxy resin MITSUI CHEMICALS, INC. (JP) 2004-12-23 US claimed
EP-1325058-A2 EPISULFIDE BASED POLYMERIZABLE COMPOSITION CATALYZED BY AN (ALKOXYPHENYL)PHOSPHINE ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2003-07-09 EP claimed
US-20020137820-A1 Phosphorus compounds SANDOZ LTD. (CH) 2002-09-26 US claimed
US-6417322-B1 HIGH SPEED CATALYSIS; POLYTHIOETHERS; OPHTHALMIC LENSES; TRANSPARENT ESSILOR INTERNATIONAL COMPAGNIE GENERAL D'OPTIQUE (FR) 2002-07-09 US claimed
US-6399779-B1 REACTING A HALOGEN AROMATIC DERIVATIVE AT A COUPLING POSITION WITH A DIBORON DERIVATIVE IN THE PRESENCE OF A GROUP 8 METAL CATALYST COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2002-06-04 US claimed
WO-2002024786-A2 EPISULFIDE BASED POLYMERIZABLE COMPOSITION CATALYZED BY AN (ALKOXYPHENYL)PHOSPHINE ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2002-03-28 WO claimed
EP-0896968-A1 MODIFIED COPOLYMER, PROCESS FOR PREPARING THE SAME, AND CURABLE RESIN COMPOSITION DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) 1999-02-17 EP claimed
US-5362775-A Seals for semiconductors or moldings NIPPONDENSO CO., LTD. (JP) 1994-11-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038305-A1 Process for producing 1-octene from butadiene OXER1, HPD, OR10J3 ALDH1A1 274/4885CA12 2100/4885CA1 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.